Ovarian function during the use of a single contraceptive implant:: Implanon compared with Norplant

被引:119
作者
Mäkäräinen, L [1 ]
van Beek, A
Tuomivaara, L
Asplund, B
Bennink, HC
机构
[1] Oulu Univ, Dept Obstet & Gynecol, FIN-90220 Oulu, Finland
[2] NV Organon, Sci Dev Grp, NL-5340 BH Oss, Netherlands
[3] Vaxjo Hosp, Dept Obstet & Gynecol, Vaxjo, Sweden
关键词
Implanon; Norplant; ovarian function; ultrasonography; contraceptive implant; etonogestrel/3-ketodesogestrel; levonorgestrel;
D O I
10.1016/S0015-0282(98)00015-6
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To study the mechanism of action of Implanon, a single-rod contraceptive implant containing etonogestrel, in healthy women during 3 years. Design: Prospective, randomized comparison with Norplant. The study was conducted for 2 years in Sweden but was extended to 3 years in Finland. Setting: Two outpatient clinics. Patient(s): Thirty-two healthy women who were between 18 and 40 years of age with normal ovulatory cycles. Seven women receiving Implanon and three receiving Norplant participated in the third year. Intervention(s): On or between days 1 and 5 of a spontaneous menstrual cycle, the subjects received either the etonogestrel-containing implant (Implanon) or the levonorgestrel-containing implant (Norplant). Main Outcome Measure(s): Ultrasonography was performed and/or progesterone concentrations were determined to confirm ovulation in a control cycle. Follicular development, endometrial thickness, and serum concentrations of 17 beta-estradiol and progesterone were assessed twice per week during 4-week periods at regular intervals and after implant removal for 6 weeks to monitor return of ovulation. Times required to remove the respective implants were evaluated, as were possible complications. Result(s): Seven women who received Implanon and three who received Norplant completed 3 years of study. There were revised and accepted no pregnancies. Ovulation was observed for the first time with Norplant after 18 months. The first ovulation with Implanon was observed after 30 months. Mean endometrial thickness was <4 mm during treatment with Implanon from month 12 onward. The mean (+/-SD) time to remove Implanon was 5.9 +/- 3.4 minutes. The mean (+/-SD) time to remove Norplant was 17.9 +/- 9.9 minutes. Ovulation resumed promptly after the use of either implant. Conclusion(s): Results from this study provide convincing evidence of 3-year contraceptive efficacy with Implanon,mainly by ovulation inhibition. (C) 1998 by American Society for Reproductive Medicine.).
引用
收藏
页码:714 / 721
页数:8
相关论文
共 20 条
[1]   Ultrasonographic and endocrine evaluation of ovarian function among Norplant(R) implants users with regular menses [J].
Alvarez, F ;
Brache, V ;
Faundes, A ;
Tejada, AS ;
Thevenin, F .
CONTRACEPTION, 1996, 54 (05) :275-279
[2]   Effects of a single contraceptive Silastic implant containing nomegestrol acetate on ovarian function and cervical mucus production during 2 years [J].
Barbosa, I ;
Coutinho, E ;
Hirsch, C ;
Ladipo, O ;
Olsson, SE ;
Ulmsten, U .
FERTILITY AND STERILITY, 1996, 65 (04) :724-729
[3]   THE ANALYSIS OF VAGINAL BLEEDING PATTERNS INDUCED BY FERTILITY REGULATING METHODS [J].
BELSEY, EM ;
MACHIN, D ;
DARCANGUES, C .
CONTRACEPTION, 1986, 34 (03) :253-260
[4]   THE ANALYSIS OF MENSTRUAL BLEEDING PATTERNS - A REVIEW (REPRINTED FROM APPLIED STOCHASTIC-MODELS AND DATA-ANALYSIS VOL 3, PG 125-150, 1987) [J].
BELSEY, EM ;
FARLEY, TMM .
CONTRACEPTION, 1988, 38 (02) :129-156
[5]  
BRACHE V, 1996, FERTIL STERIL, V65, P110
[6]   RETURN OF FERTILITY FOLLOWING DISCONTINUATION OF NORPLANT .2. SUBDERMAL IMPLANTS - ICMR TASK-FORCE ON HORMONAL CONTRACEPTION [J].
BUCKSHEE, K ;
CHATTERJEE, P ;
DHALL, GI ;
HAZRA, MN ;
KODKANY, BS ;
LALITHA, K ;
LOGAMBAL, A ;
MANCHANDA, P ;
NANDA, UK ;
RAICHOUDHURY, G ;
RAJARAM, P ;
SENGUPTA, PC ;
SIVARAMAN, R ;
SUTARIA, UD ;
ZAVERI, K ;
DATEY, S ;
GAUR, LN ;
GUPTA, NK ;
MEHTA, S ;
ROY, M ;
SAXENA, NC ;
TOPO, K ;
YADAV, SC ;
VISHWANATH, P .
CONTRACEPTION, 1995, 51 (04) :237-242
[7]   RELEASE CHARACTERISTICS, OVARIAN ACTIVITY AND MENSTRUAL BLEEDING PATTERN WITH A SINGLE CONTRACEPTIVE IMPLANT RELEASING 3-KETODESOGESTREL [J].
DAVIES, GC ;
FENG, LX ;
NEWTON, JR ;
VANBEEK, A ;
COELINGHBENNINK, HJT .
CONTRACEPTION, 1993, 47 (03) :251-261
[8]   CLINICAL-TRIAL WITH 3-KETO-DESOGESTREL SUBDERMAL IMPLANTS [J].
DIAZ, S ;
PAVEZ, M ;
MOOYOUNG, AJ ;
BARDIN, CW ;
CROXATTO, HB .
CONTRACEPTION, 1991, 44 (04) :393-408
[9]  
DONG W, 1996, J HYPERTENS, V14, P1503
[10]  
FAUNDES A, 1991, FERTIL STERIL, V56, P27